This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: University Health Network. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Keyue Ding - Innovator in Lung Cancer Prognostics
Introduction
Keyue Ding is a notable inventor based in Kingston, CA. He has made significant contributions to the field of oncology, particularly in the area of lung cancer treatment and prognosis. His innovative work focuses on improving patient outcomes through advanced genetic analysis.
Latest Patents
Keyue Ding holds a patent titled "Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy." This patent provides methods for prognosing and classifying lung cancer patients into poor survival groups or good survival groups. It also determines the benefit of adjuvant chemotherapy through a multigene signature. The application includes kits and computer products designed for use in these methods.
Career Highlights
Keyue Ding is affiliated with the University Health Network, where he continues to advance research in cancer treatment. His work has the potential to significantly impact the way lung cancer is diagnosed and treated, ultimately improving survival rates for patients.
Collaborations
Keyue has collaborated with esteemed colleagues such as Frances A. Shepherd and Sandy D. Der, who are also recognized for their contributions to cancer research.
Conclusion
Keyue Ding's innovative approach to lung cancer prognosis exemplifies the critical role of genetic research in modern medicine. His contributions are paving the way for more effective treatment strategies and better patient outcomes.